12 July 2022

At the meeting of 7 June 2022 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
hiatus hernia 60/2022 61/2022
otitis media 62/2022 63/2022
somatic symptom disorder 64/2022 65/2022
sick sinus syndrome 66/2022 67/2022
sleep apnoea 68/2022 69/2022
dermatomyositis 70/2022 71/2022
erectile dysfunction 72/2022 73/2022

These SOPs revoke the SOPs previously determined for these conditions.

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
Guillain-Barre syndrome 74/2022 75/2022
osteoarthritis 76/2022 77/2022

The above SOPs take effect from 25 July 2022.

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
restless legs syndrome Intention to remove one or more factors October 2022
allergic rhinitis Intention to remove one or more factors October 2022

Completed Investigations

The above determinations conclude the previously advertised investigations into:

New Investigation

Decided to advertise the following investigation:

  • gingivitis (focussed review - definition of 'combined oral contraceptive pill as specified')

The above investigation notice appears in the Government Notices Gazette of 4 July 2022.